157 related articles for article (PubMed ID: 2246554)
1. Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting.
Singh J; Dudley AW; Kulig KA
J Lab Clin Med; 1990 Dec; 116(6):785-9. PubMed ID: 2246554
[TBL] [Abstract][Full Text] [Related]
2. Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.
Weiss BM; Minter A; Abadie J; Howard R; Ascencao J; Schechter GP; Kuehl M; Landgren O
Am J Hematol; 2011 Jun; 86(6):475-8. PubMed ID: 21544856
[TBL] [Abstract][Full Text] [Related]
3. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.
Greenberg AJ; Vachon CM; Rajkumar SV
Leukemia; 2012 Apr; 26(4):609-14. PubMed ID: 22193966
[TBL] [Abstract][Full Text] [Related]
4. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.
Landgren O; Rajkumar SV; Pfeiffer RM; Kyle RA; Katzmann JA; Dispenzieri A; Cai Q; Goldin LR; Caporaso NE; Fraumeni JF; Blot WJ; Signorello LB
Blood; 2010 Aug; 116(7):1056-9. PubMed ID: 20421448
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.
Landgren O; Graubard BI; Kumar S; Kyle RA; Katzmann JA; Murata K; Costello R; Dispenzieri A; Caporaso N; Mailankody S; Korde N; Hultcrantz M; Therneau TM; Larson DR; Cerhan JR; Rajkumar SV
Blood Cancer J; 2017 Oct; 7(10):e618. PubMed ID: 29053158
[TBL] [Abstract][Full Text] [Related]
7. [Incidence Analysis of Monoclonal Gammopathy of Undetermined Significance in People over 40 Years of Age].
Zhang R; Wang L; Zhang ZH; Pang NN; Zhao JL; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):623-628. PubMed ID: 30998181
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.
Landgren O; Graubard BI; Katzmann JA; Kyle RA; Ahmadizadeh I; Clark R; Kumar SK; Dispenzieri A; Greenberg AJ; Therneau TM; Melton LJ; Caporaso N; Korde N; Roschewski M; Costello R; McQuillan GM; Rajkumar SV
Leukemia; 2014 Jul; 28(7):1537-42. PubMed ID: 24441287
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study.
Gupta R; Dahiya M; Kumar L; Shekhar V; Sharma A; Ramakrishnan L; Sharma OD; Begum A
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):e345-e350. PubMed ID: 29980412
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study.
Ma L; Xu S; Qu J; Hou J; Wang Y; Wen L; Liu Y; Kang Y; Jiang M; Fu W; Du J; Zhou L; Huang X; Zhang Z; Lu J;
Hematol Oncol; 2019 Feb; 37(1):75-79. PubMed ID: 30117173
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population.
Park HK; Lee KR; Kim YJ; Cho HI; Eun Kim J; Woong Kim K; Jung Kim Y; Lee KW; Hyun Kim J; Bang SM; Lee JS
Am J Hematol; 2011 Sep; 86(9):752-5. PubMed ID: 21786289
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions.
Atkin C; Reddy-Kolanu V; Drayson MT; Sapey E; Richter AG
Br J Haematol; 2020 Jun; 189(6):1127-1135. PubMed ID: 31999849
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
Landgren O; Katzmann JA; Hsing AW; Pfeiffer RM; Kyle RA; Yeboah ED; Biritwum RB; Tettey Y; Adjei AA; Larson DR; Dispenzieri A; Melton LJ; Goldin LR; McMaster ML; Caporaso NE; Rajkumar SV
Mayo Clin Proc; 2007 Dec; 82(12):1468-73. PubMed ID: 18053453
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of monoclonal gammopathy of undetermined significance in Thailand.
Watanaboonyongcharoen P; Nakorn TN; Rojnuckarin P; Lawasut P; Intragumtornchai T
Int J Hematol; 2012 Feb; 95(2):176-81. PubMed ID: 22234527
[TBL] [Abstract][Full Text] [Related]
15. Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study.
Chang SH; Luo S; Thomas TS; O'Brian KK; Colditz GA; Carlsson NP; Carson KR
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040690
[TBL] [Abstract][Full Text] [Related]
16. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
20. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]